US10912757B2ActiveUtilityA1
Product comprising red clover extract and methods for producing the same
Est. expiryDec 12, 2032(~6.4 yrs left)· nominal 20-yr term from priority
Inventors:Michael Mohr JensenPer Bendix JeppesenMax Norman Tandrup LambertAnne Cathrine Sonderstgaard Thorup
A61K 31/352A61P 15/12A61P 19/10A61K 47/46A61K 36/48A61K 35/744A61K 36/288C12P 17/06A61K 2300/00
46
PatentIndex Score
0
Cited by
18
References
25
Claims
Abstract
The invention relates to a composition comprising isoflavones from red clover. The red clover extract has been fermented to obtain a composition comprising aglycone isoflavones. The fermentation is preferably performed by a lactic acid bacteria or fermented dandelion extract.
Claims
exact text as granted — not AI-modifiedThe invention claimed is:
1. A method of making a composition comprising aglycone red clover isoflavones, the method comprising:
heating red clover to a temperature in the range of 40° C. to 100° C. for at least 15 minutes;
compressing the heated red clover to produce a liquid red clover extract;
fermenting the liquid red clover extract with one or more lactic acid bacteria species at a temperature in the range of 0° C. to 30° C. for at least 2 weeks; and
obtaining the composition from the fermented red clover extract.
2. The method according to claim 1 , wherein at least 90% of the red clover isoflavones are in an aglycone form in the composition.
3. The method according to claim 1 , wherein the fermenting is performed at a temperature in the range of 3° C. to 10° C.
4. The method according to claim 1 , wherein the fermenting is performed at a first fermentation temperature in the range of 22° C. to 25° C. for up to 3 days and then at a second temperature in the range of 15° C. to 17° C. for at least 2 weeks.
5. The method according to claim 4 , further comprising lowering the second temperature to a third fermentation temperature in the range of 3° C. to 5° C.
6. The method according to claim 1 , wherein the fermenting is performed at a first fermentation temperature in the range of 20° C. to 24° C. for up to 5 days and then at a second temperature in the range of 15° C. to 20° C. for at least 2 weeks.
7. The method according to claim 6 , further comprising lowering the second fermentation temperature to a third fermentation temperature in the range of 3° C. to 5° C.
8. The method according to claim 1 , wherein the red clover is fresh red clover.
9. The method according to claim 8 , wherein the liquid red clover extract prior to fermenting has a total dry matter content of about 6.6% (m/m).
10. The method according to claim 1 , wherein a fermented dandelion extract is added to the liquid red clover extract.
11. The method according to claim 1 , wherein the fermented red clover extract has a dry matter content in the range of 3% (m/m) to 5% (m/m).
12. The method according to claim 1 , further comprising transferring the red clover extract obtained after fermenting to a new container at an interval in the range of 1 to 12 weeks.
13. The method according to claim 1 , wherein the fermented red clover extract has a pH in the range of about 1 to about 5.
14. The method according to claim 1 , wherein the red clover is Trifolium pratense, T. pratense americanum, T. pratense frigidum, T. pratense maritimum, T. pratense parviflorum, T. pratense sativum, T. pratense villosum , or the T. pratense L varieties Rajah , Nordi, Jesper, Joioinen, or Pawera.
15. The method according to claim 1 , wherein the one or more lactic acid bacteria is Lactobacillus spp. and Bifidobacterium spp, or a combination of Lactobacillus spp. and Bifidobacterium spp.
16. The method according to claim 1 , further comprising formulating the composition as a pill, capsule, gel, mixture, liquid composition, liquid mixture, or a powder.
17. The method according to claim 1 , further comprising adding one or more of a sweetener, a carbohydrate source, a fat source, a flavouring agent, a vitamin, a mineral, an electrolyte, or a trace element to the composition.
18. The method according to claim 1 , further comprising adding a dandelion extract to the liquid red clover extract.
19. The method according to claim 1 , wherein the temperature in the heating step is in the range of 60° C. to 100° C.
20. The method according to claim 2 , wherein the isoflavone in an aglycone form is selected from the group consisting of biochanin A and Formononetin, and combinations thereof.
21. The method according to claim 1 , wherein the composition comprises Formononetin and Ononin, and the content of Formononetin is at least 90% of the sum of Formononetin and Ononin.
22. A method of making a composition comprising Formononetin and Ononin, the method comprising:
compressing red clover to produce a liquid red clover extract;
fermenting the liquid red clover extract with one or more lactic acid bacteria species at a temperature in the range of 0° C. to 20° C. for at least 2 weeks; and
obtaining the composition from the fermented red clover extract, which composition comprises at least 90% Formononetin compared to the sum of Formononetin and Ononin.
23. The method according to claim 22 , wherein no lactic acid bacteria are added to the red clover extract.
24. A method of making a composition comprising Formononetin and Ononin, the method comprising:
heating red clover to a temperature in the range of 40° C. to 100° C. for at least 15 minutes;
compressing the heated red clover to produce a liquid red clover extract;
fermenting the liquid red clover extract with one or more lactic acid bacteria species at a temperature in the range of 0° C. to 40° C. for at least 2 weeks; and
obtaining the composition from the fermented red clover extract, which composition comprises at least 90% Formononetin compared to the sum of Formononetin and Ononin.
25. The method according to claim 24 , wherein the temperature in heating step is the range of 60° C. to 100° C.Join the waitlist — get patent alerts
Track US10912757B2 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.